Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Dumping Teva Pharmaceutical Industries Limited (TEVA)

With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the first quarter. One of these stocks was Teva Pharmaceutical Industries Limited (NYSE:TEVA).

Teva Pharmaceutical Industries Limited (NYSE:TEVA) was in 32 hedge funds’ portfolios at the end of March. TEVA has experienced a decrease in support from the world’s most elite money managers in recent months. There were 35 hedge funds in our database with TEVA positions at the end of the previous quarter. Our calculations also showed that TEVA isn’t among the 30 most popular stocks among hedge funds.

Hedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ large-cap stock picks indeed failed to beat the market between 1999 and 2016. However, we were able to identify in advance a select group of hedge fund holdings that outperformed the market by 40 percentage points since May 2014 through May 30, 2019 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that’ll significantly underperform the market. We have been tracking and sharing the list of these stocks since February 2017 and they lost 30.9% through May 30, 2019. That’s why we believe hedge fund sentiment is an extremely useful indicator that investors should pay attention to.

Barry Rosenstein JANA PARTNERS

Let’s check out the new hedge fund action surrounding Teva Pharmaceutical Industries Limited (NYSE:TEVA).

What have hedge funds been doing with Teva Pharmaceutical Industries Limited (NYSE:TEVA)?

At the end of the first quarter, a total of 32 of the hedge funds tracked by Insider Monkey were long this stock, a change of -9% from one quarter earlier. On the other hand, there were a total of 28 hedge funds with a bullish position in TEVA a year ago. With hedge funds’ capital changing hands, there exists a few noteworthy hedge fund managers who were upping their stakes significantly (or already accumulated large positions).

TEVA_jun2019

The largest stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA) was held by Berkshire Hathaway, which reported holding $678.1 million worth of stock at the end of March. It was followed by Abrams Capital Management with a $283 million position. Other investors bullish on the company included Polaris Capital Management, Brahman Capital, and Highfields Capital Management.

Since Teva Pharmaceutical Industries Limited (NYSE:TEVA) has experienced bearish sentiment from the entirety of the hedge funds we track, it’s easy to see that there was a specific group of hedgies that decided to sell off their entire stakes by the end of the third quarter. Interestingly, William B. Gray’s Orbis Investment Management cut the largest position of all the hedgies followed by Insider Monkey, totaling an estimated $76.2 million in stock, and Barry Rosenstein’s JANA Partners was right behind this move, as the fund dropped about $37.8 million worth. These bearish behaviors are intriguing to say the least, as aggregate hedge fund interest was cut by 3 funds by the end of the third quarter.

Let’s now take a look at hedge fund activity in other stocks similar to Teva Pharmaceutical Industries Limited (NYSE:TEVA). We will take a look at Yum China Holdings, Inc. (NYSE:YUMC), CoStar Group Inc (NASDAQ:CSGP), Franklin Resources, Inc. (NYSE:BEN), and Total System Services, Inc. (NYSE:TSS). This group of stocks’ market values are closest to TEVA’s market value.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
YUMC 30 478911 4
CSGP 32 993601 9
BEN 28 819583 0
TSS 40 1151114 5
Average 32.5 860802 4.5

View table here if you experience formatting issues.

As you can see these stocks had an average of 32.5 hedge funds with bullish positions and the average amount invested in these stocks was $861 million. That figure was $1713 million in TEVA’s case. Total System Services, Inc. (NYSE:TSS) is the most popular stock in this table. On the other hand Franklin Resources, Inc. (NYSE:BEN) is the least popular one with only 28 bullish hedge fund positions. Teva Pharmaceutical Industries Limited (NYSE:TEVA) is not the least popular stock in this group but hedge fund interest is still below average. This is a slightly negative signal and we’d rather spend our time researching stocks that hedge funds are piling on. Our calculations showed that top 20 most popular stocks among hedge funds returned 1.9% in Q2 through May 30th and outperformed the S&P 500 ETF (SPY) by more than 3 percentage points. Unfortunately TEVA wasn’t nearly as popular as these 20 stocks (hedge fund sentiment was quite bearish); TEVA investors were disappointed as the stock returned -43.6% during the same time period and underperformed the market. If you are interested in investing in large cap stocks with huge upside potential, you should check out the top 20 most popular stocks among hedge funds as 13 of these stocks already outperformed the market so far in Q2.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...